AbCellera Biologics Inc

NASDAQ:ABCL   1:00:00 PM EDT
3.80
+0.05 (+1.33%)
4:57:56 PM EDT: $3.83 +0.03 (+0.79%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.13B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$7.26 Million
Adjusted EPS-$0.14
See more estimates
10-Day MA$3.56
50-Day MA$2.63
200-Day MA$2.72
See more pivots

AbCellera Biologics Inc Stock, NASDAQ:ABCL

150 West, 4th Avenue, Vancouver, British Columbia V5Y 1G6
Canada
Phone: +1.604.559.9005
Number of Employees: 596
http://www.abcellera.com

Description

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, V�©ronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.